The Q1 2024 investor letter from Triatomic Capital (signed by Peter Zhou, Jeff Huber, and Steve Hochberg) provides a comprehensive update on the firm’s activities, investment theses, portfolio progress, and fundraising status for Triatomic Capital Private I LP. The letter is organized around two major thematic pillars: (1) “closing the loop” in engineered biology, where AI‑driven drug discovery is hampered by bottlenecks in physical synthesis and testing, and Triatomic’s portfolio companies (Elegen Bio, Chemify, Manifold Bio, Arsenal Bio, Betteromics) are positioned to de‑bottleneck the data‑idea‑testing cycle; (2) the rising energy demands of AI and the need for next‑generation compute architectures (in‑memory compute, silicon photonics, analog computing) to make AI sustainable, highlighted by the new investment in d‑Matrix. The letter also outlines market observations (choppy valuations, limited IPO/M&A), the firm’s relocation to Palo Alto, team changes (Nikhil Nag departure), fundraising progress (final close expected Q2 2024), and detailed portfolio performance metrics (investment amounts, ownership stakes, recent KPIs). Standard legal disclosures conclude the document.

Topics

Engineered Biology Loop: From AI‑Generated Ideas to Physical Therapeutics

Discussion of the current shortcomings in AI‑driven drug discovery, the data‑idea‑testing feedback loop, and how Triatomic’s portfolio companies aim to close that loop.

Elegen Bio Investment: Next‑Gen DNA ‘Write’ Technology

Rationale for investing in Elegen Bio, its cell‑free DNA synthesis platform, and how it addresses the long lead‑times and error rates of traditional gene synthesis.

Portfolio Overview of Engineered Biology Companies

Brief profiles and recent milestones of Chemify, Manifold Bio, Arsenal Bio, Betteromics, and their roles in small‑molecule, biologics, cell‑therapy, and data‑infrastructure domains.

AI Energy Consumption Forecast and the Need for New Compute Architectures

Projection of AI‑related electricity use through 2029, identification of I/O bottlenecks, and the argument that current CPU‑GPU‑memory stacks are unsustainable.

In‑Memory Compute and d‑Matrix Investment

Explanation of in‑memory compute benefits, d‑Matrix’s claimed performance improvements (40× bandwidth, 20× power efficiency, etc.), and Triatomic’s board involvement.

Silicon Photonics and Analog Computing as Complementary Energy‑Saving Paths

Overview of how optical interconnects and continuous‑form computation can reduce data‑transport and conversion energy costs.

Fundraising Status and Final Close Timeline

Current state of capital raising for Private I LP, investor interest, and expectation of a Q2 2024 final close.

Team Relocation and Personnel Changes

Announcement of Palo Alto headquarters move, Peter Zhou’s relocation, recruitment needs, and Nikhil Nag’s departure.

More from Jeff

PDF

Triatomic Q4 2024 Private.pdf

1mo ago
PDF

Triatomic Q3 2025 Private.pdf

1mo ago
PDF

Triatomic Q3 2024 Private.pdf

1mo ago
PDF

Triatomic Q2 2025 Private.pdf

1mo ago
PDF

Triatomic Q2 2024 Private.pdf

1mo ago
PDF

Triatomic Q1 2025 Private.pdf

1mo ago
PDF

Triatomic Q4 2025 - Private.pdf

1mo ago
PDF

Triatomic Q2 2026 - Private I and II.pdf

1mo ago
PDF

Triatomic Q1 2026 - Private II.pdf

1mo ago
PDF

Triatomic Q1 2026 - Private I.pdf

1mo ago
PDF

Triatomic Q2 2025 Private.pdf

1y ago
See all content